{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:17:48Z","timestamp":1755217068940,"version":"3.43.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the epidemiological and clinical characteristics of children infected with the Omicron variant of SARS-CoV-2 during the early outbreak in Beijing, with particular attention to symptom profiles, clinical management, and persistent symptoms at 12 weeks post-infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective study enrolled children under 18 years of age with confirmed or suspected Omicron infection in Beijing between December 2022 and January 2023. Data were collected via an online questionnaire targeting both community-managed and outpatient children. A follow-up survey was conducted at 12 weeks post-infection to assess long-term symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,610 children aged 15 days to 18 years were included (median age: 3.00 years; 51.4% boys). Fever (96.4%) was the most common symptom, with a mean peak temperature of 39\u00b0C (range: 37.6\u201341\u00b0C). Other frequent symptoms included cough (59.1%), runny nose (43.7%), and fatigue (22.1%). The mean duration of fever was 2.05\u2009\u00b1\u20091.09 days, and the mean duration of all symptoms was 5.89\u2009\u00b1\u20094.35 days, with both showing significant differences across age groups (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). By one week post-infection, symptoms had resolved in 34.2% of cases. At 12 weeks, 2.9% (43\/1,471) of children still reported persistent symptoms. The most common were cough (1.4%), nasal congestion (1.1%), dry throat and exertional dyspnea (each 0.7%), and fatigue (0.6%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Omicron infection affected children across all age groups, with a higher prevalence in younger children. Fever and cough were the predominant acute symptoms, while a small subset reported mild persistent symptoms 12 weeks post-infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1389572","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:25:03Z","timestamp":1754371503000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early symptoms and 12-week follow-up of pediatric omicron infections during the Beijing outbreak"],"prefix":"10.3389","volume":"13","author":[{"given":"Qin","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00431-021-04235-4","article-title":"COVID-19 in children: clinical and epidemiological spectrum in the community","volume":"181","author":"Garc\u00eda-Vera","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/ijpvm.IJPVM_277_20","article-title":"COVID-19 infection and children: a comprehensive review","volume":"11","author":"Mehrabani","year":"2020","journal-title":"Int J Prev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.23750\/abm.v91i2.9586","article-title":"Novel coronavirus infection and children","volume":"91","author":"Cavallo","year":"2020","journal-title":"Acta Biomed"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","article-title":"Population immunity and COVID-19 severity with omicron variant in South Africa","volume":"386","author":"Madhi","year":"2022","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jiph.2022.10.006","article-title":"A systematic review of current status and challenges of vaccinating children against SARS-CoV-2","volume":"15","author":"Zhang","year":"2022","journal-title":"J Infect Public Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1140\/epjp\/s13360-021-02321-y","article-title":"Omicron: a mysterious variant of concern","volume":"137","author":"Gowrisankar","year":"2022","journal-title":"Eur Phys J Plus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa2202826","article-title":"BNT162b2 protection against the omicron variant in children and adolescents","volume":"386","author":"Price","year":"2022","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1325562","DOI":"10.3389\/fped.2024.1325562","article-title":"Clinical characteristics of 4,520 paediatric patients infected with the SARS-CoV-2 omicron variant, in Xi'an, China","volume":"12","author":"Yue","year":"2024","journal-title":"Front Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1093\/cid\/ciac275","article-title":"Coronavirus disease 2019 disease severity in children infected with the omicron variant","volume":"75","author":"Butt","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/all.15593","article-title":"Recent developments in the immunopathology of COVID-19","volume":"78","author":"Zhang","year":"2023","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1007\/s00431-022-04600-x","article-title":"Prevalence and clinical presentation of long COVID in children: a systematic review","volume":"181","author":"Pellegrino","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1111\/epi.17293","article-title":"Provoked seizures and status epilepticus in a pediatric population with COVID-19 disease","volume":"63","author":"Thongsing","year":"2022","journal-title":"Epilepsia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/irv.13044","article-title":"Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of omicron variant in Shanghai, March 7\u201331, 2022","volume":"16","author":"Wang","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"B18","doi-asserted-by":"publisher","first-page":"990944","DOI":"10.3389\/fped.2022.990944","article-title":"Clinical characteristics of children with omicron SARS-CoV-2 infection in Changchun, China from march to april 2022: a retrospective study","volume":"10","author":"Li","year":"2022","journal-title":"Front Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/ijms23041987","article-title":"Omicron genetic and clinical peculiarities that may overturn SARS-CoV-2 pandemic: a literature review","volume":"23","author":"Tiecco","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/s2214-109x(22)00114-0","article-title":"Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study","volume":"10","author":"Jassat","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/s0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1097\/inf.0000000000002937","article-title":"Sequelae of COVID-19 in hospitalized children: a 4-months follow-up","volume":"39","author":"Denina","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2167410","DOI":"10.1080\/21645515.2023.2167410","article-title":"Effectiveness of the pre-omicron COVID-19 vaccines against omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: a systematic review","volume":"19","author":"Paul","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0140-6736(22)01185-0","article-title":"Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5\u201311 years in Italy: a retrospective analysis of January\u2013April, 2022","volume":"400","author":"Sacco","year":"2022","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1094727","DOI":"10.3389\/fimmu.2022.1094727","article-title":"The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the omicron variant in children 5 to 11 years of age","volume":"13","author":"Cinicola","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/vaccines10071056","article-title":"Short-term side effects and SARS-CoV-2 infection after COVID-19 pfizer-BioNTech vaccine in children aged 5\u201311 years: an Italian real-world study","volume":"10","author":"Capponi","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/jmv.26398","article-title":"A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19)","volume":"93","author":"Cui","year":"2021","journal-title":"J Med Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00431-021-04345-z","article-title":"Long COVID symptoms and duration in SARS-CoV-2 positive children \u2014 a nationwide cohort study","volume":"181","author":"Borch","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1097\/inf.0000000000003328","article-title":"How common is long COVID in children and adolescents?","volume":"40","author":"Zimmermann","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jinf.2021.11.011","article-title":"Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies","volume":"84","author":"Behnood","year":"2022","journal-title":"J Infect"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1389572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:25:04Z","timestamp":1754371504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1389572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":30,"alternative-id":["10.3389\/fped.2025.1389572"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1389572","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"article-number":"1389572"}}